Fen Lai Tan
Direktor/Vorstandsmitglied bei Capio Biosciences, Inc.
Profil
Fen Lai Tan is currently a Director at Capio Biosciences, Inc. Prior to this, he worked as a Director, Chief Medical Officer & Senior VP at Betta Pharmaceuticals Co., Ltd.
from 2013 to 2018.
Dr. Tan holds a doctorate degree from The University of Arkansas.
Aktive Positionen von Fen Lai Tan
| Unternehmen | Position | Beginn |
|---|---|---|
Capio Biosciences, Inc.
 Capio Biosciences, Inc. BiotechnologyHealth Technology Capio Biosciences, Inc. operates as biotech company, designs and develops OncoSense CTC technology that removes circulating tumor cells from a patient's liquid biopsy. The company was founded in 2015 by Seungpyo Hong and Andrew Wang and is headquartered in Madison, WI. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Fen Lai Tan
| Unternehmen | Position | Ende |
|---|---|---|
| BETTA PHARMACEUTICALS CO., LTD. | Technik-/Wissenschafts-/F&E-Leiter | 26.03.2018 |
Ausbildung von Fen Lai Tan
| The University of Arkansas | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BETTA PHARMACEUTICALS CO., LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Capio Biosciences, Inc.
Capio Biosciences, Inc. BiotechnologyHealth Technology Capio Biosciences, Inc. operates as biotech company, designs and develops OncoSense CTC technology that removes circulating tumor cells from a patient's liquid biopsy. The company was founded in 2015 by Seungpyo Hong and Andrew Wang and is headquartered in Madison, WI. | Health Technology |
